Trial intelligence / Profile preview

Betamethasone versus placebo crossover trial in children with ataxia-telangiectasia

2008-001185-91Phase 2Completed

Sponsor
Azienda Ospedaliera Universitaria Senese
Start
May 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of betamethasone in ataxia-telangiectasia (AT) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Neurological symptoms change. Started May 2008; status: completed.

02

Drugs

betamethasone
03

Conditions

ataxia-telangiectasia (AT)

Beyond the preview

Go deeper on 2008-001185-91.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001185-91.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call